Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
– Sell
-47
Closed -$1K – 919
2019
Q2
$1K Hold
47
– – ﹤0.01% 919
2019
Q1
$1K Hold
47
– – ﹤0.01% 919
2018
Q4
$1K Hold
47
– – ﹤0.01% 894
2018
Q3
$1K Hold
47
– – ﹤0.01% 866
2018
Q2
$2K Buy
+47
New +$2.67K ﹤0.01% 816
2018
Q1
– Sell
-1,523
Closed -$120K – 943
2017
Q4
$120K Buy
+1,523
New +$123K 0.1% 142

Other funds holding ADNT

Front Row Advisors's ADNT Position: Q3 2019 in Review

Front Row Advisors sold out of Adient (ADNT) in Q3 2019, closing a stake of 47 shares — an estimated $1K sold.

Front Row Advisors first reported a position in ADNT in Q4 2017 and held it in 6 quarters. The position peaked at $120K in Q4 2017. 307 funds tracked by Wall St. Rank hold ADNT as of Q3 2019.

  • Front Row Advisors reported no remaining Adient position as of Q3 2019 after selling out during the quarter.
  • Front Row Advisors sold 47 Adient shares in Q3 2019, an estimated $1K.
  • Front Row Advisors first reported a position in Adient in Q4 2017 and held it in 6 quarters.
  • Front Row Advisors's Adient position peaked at $120K in Q4 2017.
  • 307 funds tracked by Wall St. Rank held Adient as of Q3 2019.

Based on Front Row Advisors's 13F filing for Q3 2019, filed 8 Nov 2019.